APA (7th ed.) Citation

Y, H., Z, W., X, Z., Y, L., S, J., X, W., . . . Y, J. (2026). Hyaluronic acid-mediated artemisinin/ferrocene co-delivery Nanoplatform enhances immune checkpoint blockade response by triggering tumor cell immunogenic cell death via H₂O₂-independent Chemodynamic therapy. Journal of colloid and interface science, 715, 140259. https://doi.org/10.1016/j.jcis.2026.140259

Chicago Style (17th ed.) Citation

Y, Huo, Wang Z, Zhu X, Lu Y, Jin S, Wu X, Zhang H, Tan G, and Jin Y. "Hyaluronic Acid-mediated Artemisinin/ferrocene Co-delivery Nanoplatform Enhances Immune Checkpoint Blockade Response by Triggering Tumor Cell Immunogenic Cell Death via H₂O₂-independent Chemodynamic Therapy." Journal of Colloid and Interface Science 715 (2026): 140259. https://doi.org/10.1016/j.jcis.2026.140259.

MLA (9th ed.) Citation

Y, Huo, et al. "Hyaluronic Acid-mediated Artemisinin/ferrocene Co-delivery Nanoplatform Enhances Immune Checkpoint Blockade Response by Triggering Tumor Cell Immunogenic Cell Death via H₂O₂-independent Chemodynamic Therapy." Journal of Colloid and Interface Science, vol. 715, 2026, p. 140259, https://doi.org/10.1016/j.jcis.2026.140259.